A transitional senescence program drives inflammatory monocyte state expansion in aging humans
Abstract
Dysfunctional monocyte states contribute to age-related pathologies and systemic inflammation. However, the gene regulatory networks governing the transition to these states remain unknown. Here we used bulk and single-cell multidimensional integrative profiling to reveal previously uncharacterized monocyte state transitions during human aging. We show that a transient senescent-like population arising from classical CD14++ CD16- monocytes drives the accumulation of an inflammatory monocyte state in aging humans. This senescence-associated transition is orchestrated by the master senescence regulator AP-1, which acts on a pre-established chromatin landscape to rewire the monocyte transcription factor (TF) network and activate both senescence- and age-associated inflammatory transcriptional programs. Through integration with clinical transcriptomic datasets, we demonstrate that senescent-like and aged monocytes are transcriptionally primed toward sepsis-associated states. Overall, our study provides the core gene-regulatory principles underlying a senescent-like transitional state in monocytes and identifies AP-1 as an attractive target to modulate systemic inflammation in age and disease.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that a transient senescent-like monocyte state, driven by the AP-1 transcription factor, is the primary mechanism causing the accumulation of inflammatory monocytes in aging humans. This is relevant to longevity research because it identifies a specific, upstream gene-regulatory mechanism (the AP-1-driven senescence transition) that drives systemic inflammation, a core hallmark of aging, rather than merely describing the downstream inflammatory symptoms.
Author of this paper? Send a correction.